What had been an okay-month for global equities ended with the Black Friday sell-off. The new Omicron variant roiled global markets and overshadowed the usual focus on retail spending. Typical “pandemic-winners” regained traction, while everything else fell out of favour. The dip also served as a crystal-clear reminder that the market’s trajectory hinges on the course of COVID-19. The MSCI World index ended November down -2.2%.
Detecting cancer early on can make such a big difference. The good news is that cancer screening will get much easier in the future.
February was a month of twists and turns for the healthcare industry! From the ebb and flow of macro dynamics to the ups and downs of the Q4 reporting season, healthcare stocks experienced a flurry of activity. Meanwhile, the Medtech, Pharma, and Providers space saw a surge of M&A activity. More in this month’s commentary.
Did you know that every 34 seconds a person dies in the United States from cardiovascular disease? It’s the leading cause not only in the US, but also globally.